Literature DB >> 25465195

Interdisciplinary counseling service for renal malignancies: a patient-centered approach to raise guideline adherence.

Johannes Huber1, Andreas Ihrig2, Eva Winkler3, Anette Brechtel4, Hans-Christoph Friederich4, Wolfgang Herzog4, Martin Frank5, Carsten Grüllich3, Peter Hallscheidt6, Martin Zeier7, Sascha Pahernik8, Markus Hohenfellner8.   

Abstract

OBJECTIVES: Tumor boards have become an integral part of high-quality cancer care, but in general, patients are not directly involved. To overcome this weakness, we established an interdisciplinary counseling service for renal malignancies where 4 specialists talked to the patient at once. We evaluated this approach from the patients' and physicians' perspective.
MATERIALS AND METHODS: For 3 months, we assessed organizational and clinical data. Within a standardized telephone interview lasting for 14 ± 8 minutes, we explored the patients' view 1 week after counseling. A focus group contributed the physicians' perspective. Costs and revenues were calculated from the hospital's perspective.
RESULTS: We included 52 consecutive patients aged 62 ± 10 years. Patients' initiative for a "second opinion" triggered 37% of all appointments. Patients had localized (52%) and systemic (48%) disease presenting with primary diagnosis (48%), relapse (27%), or under continuous therapy (25%). The treatment strategy was changed significantly in 16 of 30 (53%) patients reporting a specific external opinion. The most frequent changes in recommendation were nephron-sparing surgery instead of radical nephrectomy in 8 cases and divergent judgments on restaging causing changes in systemic treatment in 6 cases. We successfully interviewed 43 of 52 patients. Overall, patients rated the consultation as very positive and only 1 patient (2%) was dissatisfied. Patients rated the quality of interpersonal interaction as very positive and said they would recommend the consultation service to others. Disease state was not associated with ratings. Physicians expressed a very positive opinion, highlighting the patients' benefit and very constructive case discussions. Nevertheless, they report remarkable efforts concerning time investment and effective coordination of medical experts. We estimated a deficit of 39 Euro per patient given the German health care system. There might be relevant secondary positive economic effects for the hospital such as recommendations from one patient to another leading to acquisition of additional patients.
CONCLUSIONS: Patient involvement in multidisciplinary tumor boards is feasible and well regarded by patients and physicians likewise. By stimulating interdisciplinary collaboration, the interdisciplinary counseling service improves patient satisfaction and clinical decision making. The interdisciplinary counseling service corrected half of the external treatment plans for better guideline adherence. These positive effects come at the price of higher resource utilization. (www.germanctr.de, number DRKS00003279).
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Decision making; Guideline adherence; Patient involvement; Renal cell carcinoma

Mesh:

Year:  2014        PMID: 25465195     DOI: 10.1016/j.urolonc.2014.10.017

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  4 in total

1.  [Decision aids for patients are widely accepted by German urologists : A survey among members of the German Society of Urology (DGU) and the Federation of German Urologists (BDU)].

Authors:  C Groeben; M Baunacke; A Borkowetz; S Kliesch; C Wülfing; A Ihrig; J Huber
Journal:  Urologe A       Date:  2016-06       Impact factor: 0.639

Review 2.  Patient-Centred Coordinated Care in Times of Emerging Diseases and Epidemics. Contribution of the IMIA Working Group on Patient Safety.

Authors:  E Borycki; E Cummings; J W Dexheimer; Y Gong; S Kennebeck; A Kushniruk; C Kuziemsky; K Saranto; J Weber; H Takeda
Journal:  Yearb Med Inform       Date:  2015-06-30

3.  GUROPA survey: genito-urinary radiation oncology prescription attitudes.

Authors:  Sergio Fersino; Stefano Arcangeli; Barbara Alicja Jereczek-Fossa; Rolando D'Angelillo; Filippi Bertoni; Giuseppe Roberto D'Agostino; Luca Triggiani; Renzo Corvò; Stefano Maria Magrini; Filippo Alongi
Journal:  Radiol Med       Date:  2018-07-13       Impact factor: 3.469

4.  Factors that influence patients' views on treatment decision-making in localised kidney cancer.

Authors:  Katharina Beyer; Ravi Barod; David Nicol; Muddassar Hussain; Mieke Van Hemelrijck; Netty Kinsella
Journal:  Transl Androl Urol       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.